Diabetes mellitus and the risk of urinary tract stones: A population-based case-control study

被引:118
作者
Lieske, John C.
de la Vega, Lourdes S. Pena
Gettman, Matthew T.
Slezak, Jeffrey M.
Bergstralh, Eric J.
Melton, Joseph, III
Leibson, Cynthia L.
机构
[1] Mayo Clin, Div Nephrol & Hypertens, Coll Med, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Div Biostat, Rochester, MN 55905 USA
[3] Mayo Clin, Coll Med, Div Epidemiol, Rochester, MN 55905 USA
[4] Mayo Clin, Coll Med, Dept Urol, Rochester, MN USA
[5] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN USA
关键词
diabetes; hypertension; nephrolithiasis; obesity; uric acid;
D O I
10.1053/j.ajkd.2006.09.002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Because nephrolithiasis has been associated with obesity, an important risk factor for type 2 diabetes mellitus (DM), we tested the hypothesis that DM prevalence is increased in individuals who develop renal stones. Methods: In an initial electronic analysis, prior diagnoses of DM, hypertension, and obesity were compared between all Olmsted County, MN, residents with a diagnosis code for nephrolithiasis between 1980 and 1999 and matched residents of similar age and sex (N = 3,561 case-control pairs). A random sample of 260 cases and corresponding controls was selected for detailed medical record review to confirm and characterize the stone event and obtain heights, weights, blood pressures, and glucose and cholesterol values. Results: In the electronic analysis, unadjusted odds ratios! (ORs) for DM (OR, 1.29; 95% confidence interval [Cl], 1.09 to 1.53), obesity (OR, 1.15; 95% Cl, 1.02 to 1.31), and hypertension (OR, 1.19; 95% Cl, 1.04 to 1.35) were increased significantly for nephrolithiasis cases versus controls; DM remained significant after adjustment for age, sex, calendar year, hypertension, and obesity (OR, 1.22; 95% Cl, 1.03 to 1.46). Detailed record review of a subset showed significant increases for cases versus controls for body mass index (OR, 1.05; 95% Cl, 1.01 to -1.09) and hypertension (OR, 1.71; 95% Cl, 1.17 to 2.59). Odds for DM were increased, but not significantly, in the subsample (OR, 1.44; 95% Cl, 0.76 to 2.72). Among cases with stone analyses, those with uric acid stones (n = 10) had a greater percentage of DM compared with those with all other stone types (n = 112; 40% versus 9%; P = 0.02). Conclusion: Findings from this population-based study suggest that DM, obesity, and hypertension are associated with nephrolithiasis, and DM may be a factor in the development of uric acid stones.
引用
收藏
页码:897 / 904
页数:8
相关论文
共 32 条
[1]   The metabolic syndrome and uric acid nephrolithiasis: Novel features of renal manifestation of insulin resistance [J].
Abate, N ;
Chandalia, M ;
Cabo-Chan, AV ;
Moe, OW ;
Sakhaee, K .
KIDNEY INTERNATIONAL, 2004, 65 (02) :386-392
[2]   Impact of case ascertainment on recent trends in diabetes incidence in Rochester, Minnesota [J].
Burke, JP ;
O'Brien, P ;
Ransom, J ;
Palumbo, PJ ;
Lydick, E ;
Yawn, BP ;
Melton, LJ ;
Leibson, CL .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (09) :859-865
[3]   INSULIN STIMULATES AMMONIAGENESIS IN CANINE RENAL PROXIMAL TUBULAR SEGMENTS [J].
CHOBANIAN, MC ;
HAMMERMAN, MR .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 253 (06) :F1171-F1177
[4]   A PROSPECTIVE-STUDY OF DIETARY CALCIUM AND OTHER NUTRIENTS AND THE RISK OF SYMPTOMATIC KIDNEY-STONES [J].
CURHAN, GC ;
WILLETT, WC ;
RIMM, EB ;
STAMPFER, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (12) :833-838
[5]  
Curhan GC, 1998, J AM SOC NEPHROL, V9, P1645
[6]   Predictors of progression from impaired glucose tolerance to NIDDM - An analysis of six prospective studies [J].
Edelstein, SL ;
Knowler, WC ;
Bain, RP ;
Andres, R ;
BarrettConnor, EL ;
Dowse, GK ;
Haffner, SM ;
Pettitt, DJ ;
Sorkin, JD ;
Muller, DC ;
Collins, VR ;
Hamman, RF .
DIABETES, 1997, 46 (04) :701-710
[7]   Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients [J].
Ekeruo, WO ;
Tan, YH ;
Young, MD ;
Dahm, P ;
Maloney, ME ;
Mathias, BJ ;
Albala, DM ;
Preminger, GM .
JOURNAL OF UROLOGY, 2004, 172 (01) :159-163
[8]   CHLORTHALIDONE REDUCES CALCIUM-OXALATE CALCULOUS RECURRENCE BUT MAGNESIUM-HYDROXIDE DOES NOT [J].
ETTINGER, B ;
CITRON, JT ;
LIVERMORE, B ;
DOLMAN, LI .
JOURNAL OF UROLOGY, 1988, 139 (04) :679-684
[9]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359
[10]   Trends and correlates of class 3 obesity in the United States from 1990 through 2000 [J].
Freedman, DS ;
Khan, LK ;
Serdula, MK ;
Galuska, DA ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (14) :1758-1761